Physician

Matthew T Witmer, MD

According to 2025 Medicare claims, Matthew Witmer, MD (NPI: 1235321167) practices ophthalmology in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF WESTERN NY PC (NPI: 1295811560; TIN: 161182825) and primary practice location at 14620-4655. Witmer is affiliated with the NewYork Quality Care (ACO ID: A2571) and Rochester Regional Health ACO, Inc. (ACO ID: A3476), participating under the MSSP model.

Witmer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 335 traditional Medicare patients, billed 8,411 HCPCS/CPT codes, and received $862,926 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 651 prescription claims across 209 beneficiaries totaling $19,568 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 32 records totaling $36,120. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $18,491 to $19,568. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	955	7,579	$1,389,039
2016	517	2,290	$179,375
2017	297	2,546	$259,883
2018	371	3,330	$387,622
2019	387	3,590	$611,198
2020	395	3,542	$797,932
2021	379	3,420	$753,653
2022	372	4,538	$867,193
2023	389	8,983	$996,981
2024	335	8,411	$862,926

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	122	339	$18,491
2016	61	130	$6,909
2017	125	346	$13,312
2018	151	417	$20,427
2019	169	479	$17,928
2020	182	494	$19,485
2021	190	574	$28,677
2022	203	596	$27,460
2023	236	676	$27,588
2024	209	651	$19,568

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	82	754	$658
67028	Injection of drug into eye	134	526	$90
92014	Established patient complete exam of visual system	239	322	$90
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	51	71	$37
92134	Imaging of retina	300	696	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	154	9,276	$9,422
Brimonidine Tartrate	Brimonidine Tartrate	41	2,704	$2,715
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	98	7,855	$1,591
Valacyclovir	Valacyclovir Hcl	22	840	$824
Acetazolamide	Acetazolamide	11	450	$685

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$14,516	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$21,604	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew T. Witmer, MD?

Tedicare shows public-source Medicare data for Matthew T. Witmer, MD (NPI 1235321167), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew T. Witmer, MD have ACO affiliation data?

Matthew T. Witmer, MD is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571) and Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476).

What billing organization is linked to Matthew T. Witmer, MD?

Matthew T. Witmer, MD is linked to RETINA ASSOCIATES OF WESTERN NY PC (billing NPI 1295811560) in the available physician profile data.

Does Matthew T. Witmer, MD have Open Payments data?

Matthew T. Witmer, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.